When researchers screen potential tuberculosis drugs, they often end up with too many options. Some look promising but later prove to be costly dead ends. "We might get thousands of compounds from a screen and then have
Tuberculosis drug discovery gets smarter with AI
When researchers screen potential tuberculosis drugs, they often end up with too many options. Some look promising but later prove to be costly dead ends. "We might get thousands o
